We are live on ! Find out more
RC

Roundview Capital Portfolio holdings

AUM $1.83B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+18.41%
1 Year Est. Return
+26.02%
3 Year Est. Return
+77.66%
5 Year Est. Return
+94.56%
10 Year Est. Return
+341.66%
AUM
$589M
AUM Growth
+$116M
Cap. Flow
+$38.3M
Cap. Flow %
6.5%
Top 10 Hldgs %
30.24%
Holding
242
New
23
Increased
100
Reduced
102
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 14.7%
2 Financials 11.49%
3 Healthcare 8.19%
4 Communication Services 7.12%
5 Consumer Discretionary 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LH icon
126
Labcorp
LH
$25.9B
$1.11M 0.19%
7,779
-3,919
-34% -$542K
BN icon
127
Brookfield
BN
$103B
$1.1M 0.19%
62,721
+3,760
+6% +$66.1K
C icon
128
Citigroup
C
$222B
$1.1M 0.19%
21,471
-1,292
-6% -$61.3K
PSX icon
129
Phillips 66
PSX
$84.4B
$1.1M 0.19%
15,242
+5,147
+51% +$364K
CHD icon
130
Church & Dwight Co
CHD
$23.1B
$1.09M 0.19%
14,117
-1,062
-7% -$77.3K
PPG icon
131
PPG Industries
PPG
$25B
$1.07M 0.18%
10,055
+3,913
+64% +$377K
RSP icon
132
Invesco S&P 500 Equal Weight ETF
RSP
$97.2B
$1.04M 0.18%
10,197
-1,647
-14% -$159K
DIA icon
133
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.5B
$1.01M 0.17%
3,911
-130
-3% -$32K
NSC icon
134
Norfolk Southern
NSC
$75B
$977K 0.17%
5,567
+50
+0.9% +$8.47K
SPTM icon
135
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$971K 0.16%
25,712
-2,610
-9% -$93.3K
WBA
136
DELISTED
Walgreens Boots Alliance
WBA
$957K 0.16%
22,575
-300
-1% -$12.7K
SCHH icon
137
Schwab US REIT ETF
SCHH
$11.5B
$947K 0.16%
53,762
-40,214
-43% -$698K
MCO icon
138
Moody's
MCO
$83.5B
$939K 0.16%
3,419
-72
-2% -$18.3K
CLX icon
139
Clorox
CLX
$11.7B
$937K 0.16%
4,273
+168
+4% +$33.6K
IEFA icon
140
iShares Core MSCI EAFE ETF
IEFA
$192B
$912K 0.15%
15,958
+1,318
+9% +$71.4K
BA icon
141
Boeing
BA
$175B
$903K 0.15%
4,928
-1,179
-19% -$181K
DEO icon
142
Diageo
DEO
$49.5B
$890K 0.15%
6,620
-128
-2% -$17.6K
UN
143
DELISTED
Unilever NV New York Registry Shares
UN
$884K 0.15%
16,586
-7,577
-31% -$385K
EDIV icon
144
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$864K 0.15%
34,952
-435
-1% -$10.6K
CI icon
145
Cigna
CI
$76.1B
$854K 0.15%
4,552
-159
-3% -$30.2K
LMT icon
146
Lockheed Martin
LMT
$132B
$851K 0.14%
2,331
+131
+6% +$49.5K
NVS icon
147
Novartis
NVS
$301B
$847K 0.14%
9,695
-202
-2% -$17.4K
NVR icon
148
NVR
NVR
$16.8B
$844K 0.14%
259
+97
+60% +$297K
BABA icon
149
Alibaba
BABA
$279B
$835K 0.14%
3,870
-3,640
-48% -$758K
LUV icon
150
Southwest Airlines
LUV
$22.3B
$833K 0.14%
24,373
-27,180
-53% -$864K

Similar funds

Roundview Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Roundview Capital held 242 positions worth $589M, up 24% from $473M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Roundview Capital deployed $38.3M of net new capital in Q2 2020, opening 23 new positions and adding to 100 existing holdings. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 75,835 shares worth $4.15M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $2.11M trimmed.

  • Roundview Capital's largest Q2 2020 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 75,835 shares worth $4.15M.
  • Roundview Capital added most to Vanguard Short-Term Corporate Bond ETF in Q2 2020, an estimated $12.7M increase.
  • Roundview Capital's biggest Q2 2020 reduction was Berkshire Hathaway Class B, cutting an estimated $2.11M.
  • Roundview Capital fully exited iShares MSCI Emerging Markets ETF in Q2 2020, selling an estimated $6.37M.
  • Roundview Capital's ten largest holdings make up 30% of its $589M portfolio in Q2 2020.
  • Roundview Capital opened 23 new positions and closed 9 in Q2 2020.
  • Roundview Capital's portfolio value rose 24% quarter-over-quarter to $589M.

Based on Roundview Capital's 13F filing for Q2 2020, filed 13 Aug 2020.